257 related articles for article (PubMed ID: 23172908)
1. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
[TBL] [Abstract][Full Text] [Related]
2. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS.
Chitramuthu BP; Kay DG; Bateman A; Bennett HP
PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
[TBL] [Abstract][Full Text] [Related]
5. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
Nguyen T; Hamby A; Massa SM
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
[TBL] [Abstract][Full Text] [Related]
6. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.
Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ
Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334
[TBL] [Abstract][Full Text] [Related]
7. Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans.
Vaccaro A; Tauffenberger A; Aggad D; Rouleau G; Drapeau P; Parker JA
PLoS One; 2012; 7(2):e31321. PubMed ID: 22363618
[TBL] [Abstract][Full Text] [Related]
8. Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington's disease.
Mori S; Honda H; Ishii T; Yoshimura M; Sasagasako N; Suzuki SO; Taniwaki T; Iwaki T
Neuropathology; 2019 Oct; 39(5):358-367. PubMed ID: 31599037
[TBL] [Abstract][Full Text] [Related]
9. Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.
Nishimura Y; Yalgin C; Akimoto S; Doumanis J; Sasajima R; Nukina N; Miyakawa H; Moore AW; Morimoto T
J Neurogenet; 2010 Dec; 24(4):194-206. PubMed ID: 21087194
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.
Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM
Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481
[TBL] [Abstract][Full Text] [Related]
11. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
[TBL] [Abstract][Full Text] [Related]
12. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH; Li XJ
Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.
Schwab C; Arai T; Hasegawa M; Yu S; McGeer PL
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1159-65. PubMed ID: 19018245
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
Truant R; Atwal RS; Burtnik A
Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells.
Colombrita C; Onesto E; Megiorni F; Pizzuti A; Baralle FE; Buratti E; Silani V; Ratti A
J Biol Chem; 2012 May; 287(19):15635-47. PubMed ID: 22427648
[TBL] [Abstract][Full Text] [Related]
17. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
18. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
[TBL] [Abstract][Full Text] [Related]
19. The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels.
Salazar DA; Butler VJ; Argouarch AR; Hsu TY; Mason A; Nakamura A; McCurdy H; Cox D; Ng R; Pan G; Seeley WW; Miller BL; Kao AW
J Neurosci; 2015 Jun; 35(25):9315-28. PubMed ID: 26109656
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
